nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP2C9—brain cancer	0.354	1	CbGaD
Progesterone—CYP1B1—Procarbazine—brain cancer	0.213	0.522	CbGbCtD
Progesterone—ABCC1—Etoposide—brain cancer	0.0311	0.0762	CbGbCtD
Progesterone—CYP2D6—Lomustine—brain cancer	0.0293	0.0717	CbGbCtD
Progesterone—CYP1A2—Carmustine—brain cancer	0.029	0.0709	CbGbCtD
Progesterone—CYP2D6—Hydroxyurea—brain cancer	0.0222	0.0543	CbGbCtD
Progesterone—CYP3A4—Temozolomide—brain cancer	0.0219	0.0536	CbGbCtD
Progesterone—CYP3A4—Lomustine—brain cancer	0.0186	0.0456	CbGbCtD
Progesterone—CYP3A5—Etoposide—brain cancer	0.0115	0.0282	CbGbCtD
Progesterone—CYP2C8—Etoposide—brain cancer	0.0111	0.0272	CbGbCtD
Progesterone—CYP1A2—Etoposide—brain cancer	0.00859	0.021	CbGbCtD
Progesterone—ABCB1—Etoposide—brain cancer	0.00751	0.0184	CbGbCtD
Progesterone—CYP3A4—Etoposide—brain cancer	0.0045	0.011	CbGbCtD
Progesterone—SLC22A1—ganglion—brain cancer	0.00111	0.0267	CbGeAlD
Progesterone—SHBG—hindbrain—brain cancer	0.000979	0.0235	CbGeAlD
Progesterone—NR3C2—hindbrain—brain cancer	0.000948	0.0227	CbGeAlD
Progesterone—PGR—blood vessel—brain cancer	0.000924	0.0221	CbGeAlD
Progesterone—Trilostane—ESR2—brain cancer	0.000887	0.641	CrCbGaD
Progesterone—PGR—hindbrain—brain cancer	0.000882	0.0211	CbGeAlD
Progesterone—ESR1—blood vessel—brain cancer	0.000723	0.0173	CbGeAlD
Progesterone—ESR1—hindbrain—brain cancer	0.00069	0.0165	CbGeAlD
Progesterone—SLC10A1—gonad—brain cancer	0.00064	0.0153	CbGeAlD
Progesterone—SHBG—brainstem—brain cancer	0.000561	0.0134	CbGeAlD
Progesterone—CYP17A1—gonad—brain cancer	0.000557	0.0134	CbGeAlD
Progesterone—NR3C2—brainstem—brain cancer	0.000544	0.013	CbGeAlD
Progesterone—CYP17A1—medulla oblongata—brain cancer	0.000525	0.0126	CbGeAlD
Progesterone—NR3C1—hindbrain—brain cancer	0.000509	0.0122	CbGeAlD
Progesterone—SLC10A1—endocrine gland—brain cancer	0.000483	0.0116	CbGeAlD
Progesterone—NR3C2—telencephalon—brain cancer	0.000482	0.0116	CbGeAlD
Progesterone—ABCB11—endocrine gland—brain cancer	0.000478	0.0114	CbGeAlD
Progesterone—SLC10A1—head—brain cancer	0.000477	0.0114	CbGeAlD
Progesterone—CYP3A7—endocrine gland—brain cancer	0.000467	0.0112	CbGeAlD
Progesterone—SLC10A1—central nervous system—brain cancer	0.000436	0.0104	CbGeAlD
Progesterone—SLC22A1—telencephalon—brain cancer	0.000429	0.0103	CbGeAlD
Progesterone—CYP17A1—endocrine gland—brain cancer	0.000421	0.0101	CbGeAlD
Progesterone—OPRK1—head—brain cancer	0.00042	0.0101	CbGeAlD
Progesterone—CYP17A1—head—brain cancer	0.000416	0.00996	CbGeAlD
Progesterone—SHBG—gonad—brain cancer	0.000415	0.00995	CbGeAlD
Progesterone—SHBG—pituitary gland—brain cancer	0.000405	0.00971	CbGeAlD
Progesterone—SIGMAR1—telencephalon—brain cancer	0.000397	0.00951	CbGeAlD
Progesterone—ESR1—brainstem—brain cancer	0.000395	0.00947	CbGeAlD
Progesterone—NR3C2—pituitary gland—brain cancer	0.000393	0.00941	CbGeAlD
Progesterone—OPRK1—central nervous system—brain cancer	0.000384	0.0092	CbGeAlD
Progesterone—CYP17A1—central nervous system—brain cancer	0.00038	0.00909	CbGeAlD
Progesterone—NR3C2—medulla oblongata—brain cancer	0.000379	0.00908	CbGeAlD
Progesterone—CYP2D6—hindbrain—brain cancer	0.000379	0.00907	CbGeAlD
Progesterone—CYP1B1—telencephalon—brain cancer	0.000377	0.00904	CbGeAlD
Progesterone—OPRK1—cerebellum—brain cancer	0.000375	0.00899	CbGeAlD
Progesterone—PGR—pituitary gland—brain cancer	0.000365	0.00875	CbGeAlD
Progesterone—AR—telencephalon—brain cancer	0.000357	0.00856	CbGeAlD
Progesterone—ESR1—telencephalon—brain cancer	0.000351	0.0084	CbGeAlD
Progesterone—NR3C2—midbrain—brain cancer	0.000346	0.0083	CbGeAlD
Progesterone—SLC10A1—brain—brain cancer	0.000346	0.00829	CbGeAlD
Progesterone—SLC22A3—gonad—brain cancer	0.000343	0.00821	CbGeAlD
Progesterone—ABCC1—telencephalon—brain cancer	0.000339	0.00813	CbGeAlD
Progesterone—NR3C2—spinal cord—brain cancer	0.000338	0.0081	CbGeAlD
Progesterone—SIGMAR1—pituitary gland—brain cancer	0.000323	0.00774	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.000322	0.233	CrCbGaD
Progesterone—CYP1B1—gonad—brain cancer	0.000315	0.00754	CbGeAlD
Progesterone—SHBG—endocrine gland—brain cancer	0.000314	0.00752	CbGeAlD
Progesterone—SIGMAR1—medulla oblongata—brain cancer	0.000312	0.00747	CbGeAlD
Progesterone—CYP1B1—pituitary gland—brain cancer	0.000307	0.00736	CbGeAlD
Progesterone—OPRK1—brain—brain cancer	0.000305	0.0073	CbGeAlD
Progesterone—NR3C2—endocrine gland—brain cancer	0.000304	0.00729	CbGeAlD
Progesterone—CYP17A1—brain—brain cancer	0.000301	0.00722	CbGeAlD
Progesterone—NR3C2—head—brain cancer	0.0003	0.0072	CbGeAlD
Progesterone—AR—gonad—brain cancer	0.000298	0.00714	CbGeAlD
Progesterone—ESR1—gonad—brain cancer	0.000293	0.00701	CbGeAlD
Progesterone—NR3C1—brainstem—brain cancer	0.000292	0.00699	CbGeAlD
Progesterone—AR—pituitary gland—brain cancer	0.000291	0.00697	CbGeAlD
Progesterone—CYP2A6—cerebellum—brain cancer	0.000286	0.00685	CbGeAlD
Progesterone—ESR1—pituitary gland—brain cancer	0.000286	0.00684	CbGeAlD
Progesterone—ABCB1—blood vessel—brain cancer	0.000286	0.00684	CbGeAlD
Progesterone—SIGMAR1—midbrain—brain cancer	0.000285	0.00683	CbGeAlD
Progesterone—SHBG—central nervous system—brain cancer	0.000283	0.00678	CbGeAlD
Progesterone—PGR—endocrine gland—brain cancer	0.000283	0.00678	CbGeAlD
Progesterone—PGR—head—brain cancer	0.000279	0.00669	CbGeAlD
Progesterone—SIGMAR1—spinal cord—brain cancer	0.000278	0.00666	CbGeAlD
Progesterone—SHBG—cerebellum—brain cancer	0.000277	0.00663	CbGeAlD
Progesterone—ABCC1—pituitary gland—brain cancer	0.000276	0.00662	CbGeAlD
Progesterone—NR3C2—central nervous system—brain cancer	0.000274	0.00657	CbGeAlD
Progesterone—SLC22A1—endocrine gland—brain cancer	0.000271	0.00649	CbGeAlD
Progesterone—NR3C2—cerebellum—brain cancer	0.000268	0.00642	CbGeAlD
Progesterone—SLC22A1—head—brain cancer	0.000267	0.00641	CbGeAlD
Progesterone—SLC22A3—endocrine gland—brain cancer	0.000259	0.0062	CbGeAlD
Progesterone—NR3C1—telencephalon—brain cancer	0.000259	0.0062	CbGeAlD
Progesterone—SLC22A3—head—brain cancer	0.000256	0.00612	CbGeAlD
Progesterone—PGR—central nervous system—brain cancer	0.000255	0.00611	CbGeAlD
Progesterone—AR—spinal cord—brain cancer	0.00025	0.006	CbGeAlD
Progesterone—PGR—cerebellum—brain cancer	0.000249	0.00597	CbGeAlD
Progesterone—SLC22A1—central nervous system—brain cancer	0.000244	0.00585	CbGeAlD
Progesterone—CYP1B1—endocrine gland—brain cancer	0.000238	0.0057	CbGeAlD
Progesterone—CYP2C8—pituitary gland—brain cancer	0.000235	0.00564	CbGeAlD
Progesterone—CYP1B1—head—brain cancer	0.000235	0.00563	CbGeAlD
Progesterone—SLC22A3—central nervous system—brain cancer	0.000233	0.00559	CbGeAlD
Progesterone—CYP2A6—brain—brain cancer	0.000232	0.00556	CbGeAlD
Progesterone—Neuropathy peripheral—Carmustine—brain cancer	0.00023	0.00183	CcSEcCtD
Progesterone—Hyperglycaemia—Temozolomide—brain cancer	0.00023	0.00183	CcSEcCtD
Progesterone—Urinary tract infection—Carmustine—brain cancer	0.000228	0.00182	CcSEcCtD
Progesterone—Pneumonia—Temozolomide—brain cancer	0.000228	0.00182	CcSEcCtD
Progesterone—Anorexia—Procarbazine—brain cancer	0.000228	0.00182	CcSEcCtD
Progesterone—Erythema—Hydroxyurea—brain cancer	0.000227	0.00181	CcSEcCtD
Progesterone—Infestation—Temozolomide—brain cancer	0.000227	0.00181	CcSEcCtD
Progesterone—Infestation NOS—Temozolomide—brain cancer	0.000227	0.00181	CcSEcCtD
Progesterone—Depression—Temozolomide—brain cancer	0.000226	0.0018	CcSEcCtD
Progesterone—AR—endocrine gland—brain cancer	0.000225	0.0054	CbGeAlD
Progesterone—SHBG—brain—brain cancer	0.000225	0.00538	CbGeAlD
Progesterone—Nausea—Lomustine—brain cancer	0.000224	0.00178	CcSEcCtD
Progesterone—Hypotension—Procarbazine—brain cancer	0.000224	0.00178	CcSEcCtD
Progesterone—Neuropathy peripheral—Temozolomide—brain cancer	0.000223	0.00177	CcSEcCtD
Progesterone—AR—head—brain cancer	0.000222	0.00533	CbGeAlD
Progesterone—ESR1—endocrine gland—brain cancer	0.000221	0.0053	CbGeAlD
Progesterone—Urinary tract infection—Temozolomide—brain cancer	0.000221	0.00176	CcSEcCtD
Progesterone—SIGMAR1—cerebellum—brain cancer	0.00022	0.00528	CbGeAlD
Progesterone—ESR1—head—brain cancer	0.000218	0.00523	CbGeAlD
Progesterone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000218	0.00174	CcSEcCtD
Progesterone—NR3C2—brain—brain cancer	0.000218	0.00522	CbGeAlD
Progesterone—CYP2D6—brainstem—brain cancer	0.000217	0.0052	CbGeAlD
Progesterone—Insomnia—Procarbazine—brain cancer	0.000217	0.00172	CcSEcCtD
Progesterone—NR3C1—gonad—brain cancer	0.000216	0.00517	CbGeAlD
Progesterone—Paraesthesia—Procarbazine—brain cancer	0.000215	0.00171	CcSEcCtD
Progesterone—Hepatobiliary disease—Temozolomide—brain cancer	0.000215	0.00171	CcSEcCtD
Progesterone—CYP1B1—central nervous system—brain cancer	0.000214	0.00514	CbGeAlD
Progesterone—Sinusitis—Temozolomide—brain cancer	0.000213	0.0017	CcSEcCtD
Progesterone—Somnolence—Procarbazine—brain cancer	0.000213	0.0017	CcSEcCtD
Progesterone—Cramp muscle—Etoposide—brain cancer	0.000212	0.00169	CcSEcCtD
Progesterone—Haemoglobin—Carmustine—brain cancer	0.000212	0.00169	CcSEcCtD
Progesterone—Haemorrhage—Carmustine—brain cancer	0.000211	0.00168	CcSEcCtD
Progesterone—NR3C1—pituitary gland—brain cancer	0.000211	0.00505	CbGeAlD
Progesterone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000211	0.00168	CcSEcCtD
Progesterone—Anaemia—Hydroxyurea—brain cancer	0.00021	0.00167	CcSEcCtD
Progesterone—CYP1B1—cerebellum—brain cancer	0.00021	0.00502	CbGeAlD
Progesterone—CYP2C19—endocrine gland—brain cancer	0.000209	0.005	CbGeAlD
Progesterone—Decreased appetite—Procarbazine—brain cancer	0.000208	0.00166	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Etoposide—brain cancer	0.000208	0.00166	CcSEcCtD
Progesterone—Oedema peripheral—Carmustine—brain cancer	0.000208	0.00165	CcSEcCtD
Progesterone—Connective tissue disorder—Carmustine—brain cancer	0.000207	0.00165	CcSEcCtD
Progesterone—Fatigue—Procarbazine—brain cancer	0.000206	0.00164	CcSEcCtD
Progesterone—Haemoglobin—Temozolomide—brain cancer	0.000205	0.00163	CcSEcCtD
Progesterone—Malaise—Hydroxyurea—brain cancer	0.000205	0.00163	CcSEcCtD
Progesterone—Pain—Procarbazine—brain cancer	0.000205	0.00163	CcSEcCtD
Progesterone—Constipation—Procarbazine—brain cancer	0.000205	0.00163	CcSEcCtD
Progesterone—Haemorrhage—Temozolomide—brain cancer	0.000204	0.00162	CcSEcCtD
Progesterone—Hepatitis—Temozolomide—brain cancer	0.000204	0.00162	CcSEcCtD
Progesterone—Dysphagia—Etoposide—brain cancer	0.000204	0.00162	CcSEcCtD
Progesterone—NR3C1—medulla oblongata—brain cancer	0.000203	0.00487	CbGeAlD
Progesterone—Visual impairment—Carmustine—brain cancer	0.000203	0.00162	CcSEcCtD
Progesterone—AR—central nervous system—brain cancer	0.000203	0.00487	CbGeAlD
Progesterone—PGR—brain—brain cancer	0.000202	0.00485	CbGeAlD
Progesterone—Pharyngitis—Temozolomide—brain cancer	0.000202	0.00161	CcSEcCtD
Progesterone—Urinary tract disorder—Temozolomide—brain cancer	0.000201	0.0016	CcSEcCtD
Progesterone—Oedema peripheral—Temozolomide—brain cancer	0.000201	0.0016	CcSEcCtD
Progesterone—Connective tissue disorder—Temozolomide—brain cancer	0.0002	0.00159	CcSEcCtD
Progesterone—Urethral disorder—Temozolomide—brain cancer	0.0002	0.00159	CcSEcCtD
Progesterone—ESR1—central nervous system—brain cancer	0.000199	0.00478	CbGeAlD
Progesterone—Sweating increased—Etoposide—brain cancer	0.000198	0.00158	CcSEcCtD
Progesterone—Feeling abnormal—Procarbazine—brain cancer	0.000197	0.00157	CcSEcCtD
Progesterone—Eye disorder—Carmustine—brain cancer	0.000197	0.00157	CcSEcCtD
Progesterone—Convulsion—Hydroxyurea—brain cancer	0.000197	0.00157	CcSEcCtD
Progesterone—Visual impairment—Temozolomide—brain cancer	0.000196	0.00156	CcSEcCtD
Progesterone—Gastrointestinal pain—Procarbazine—brain cancer	0.000196	0.00156	CcSEcCtD
Progesterone—ESR1—cerebellum—brain cancer	0.000195	0.00467	CbGeAlD
Progesterone—SLC22A1—brain—brain cancer	0.000194	0.00464	CbGeAlD
Progesterone—Erythema multiforme—Temozolomide—brain cancer	0.000193	0.00153	CcSEcCtD
Progesterone—CYP2D6—telencephalon—brain cancer	0.000193	0.00461	CbGeAlD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000192	0.00153	CcSEcCtD
Progesterone—Discomfort—Hydroxyurea—brain cancer	0.000191	0.00152	CcSEcCtD
Progesterone—Eye disorder—Temozolomide—brain cancer	0.00019	0.00152	CcSEcCtD
Progesterone—Urticaria—Procarbazine—brain cancer	0.00019	0.00151	CcSEcCtD
Progesterone—Tinnitus—Temozolomide—brain cancer	0.00019	0.00151	CcSEcCtD
Progesterone—Body temperature increased—Procarbazine—brain cancer	0.000189	0.00151	CcSEcCtD
Progesterone—Abdominal pain—Procarbazine—brain cancer	0.000189	0.00151	CcSEcCtD
Progesterone—Cardiac disorder—Temozolomide—brain cancer	0.000189	0.00151	CcSEcCtD
Progesterone—ABCC1—cerebellum—brain cancer	0.000189	0.00452	CbGeAlD
Progesterone—Alopecia—Carmustine—brain cancer	0.000186	0.00148	CcSEcCtD
Progesterone—NR3C1—midbrain—brain cancer	0.000186	0.00445	CbGeAlD
Progesterone—Oedema—Hydroxyurea—brain cancer	0.000185	0.00148	CcSEcCtD
Progesterone—SLC22A3—brain—brain cancer	0.000185	0.00444	CbGeAlD
Progesterone—Angiopathy—Temozolomide—brain cancer	0.000185	0.00147	CcSEcCtD
Progesterone—Mental disorder—Carmustine—brain cancer	0.000185	0.00147	CcSEcCtD
Progesterone—Infection—Hydroxyurea—brain cancer	0.000184	0.00147	CcSEcCtD
Progesterone—Immune system disorder—Temozolomide—brain cancer	0.000184	0.00147	CcSEcCtD
Progesterone—Mediastinal disorder—Temozolomide—brain cancer	0.000184	0.00146	CcSEcCtD
Progesterone—Malnutrition—Carmustine—brain cancer	0.000184	0.00146	CcSEcCtD
Progesterone—Erythema—Carmustine—brain cancer	0.000184	0.00146	CcSEcCtD
Progesterone—Pneumonia—Etoposide—brain cancer	0.000183	0.00145	CcSEcCtD
Progesterone—CYP2C8—endocrine gland—brain cancer	0.000182	0.00437	CbGeAlD
Progesterone—Nervous system disorder—Hydroxyurea—brain cancer	0.000182	0.00145	CcSEcCtD
Progesterone—Infestation NOS—Etoposide—brain cancer	0.000182	0.00145	CcSEcCtD
Progesterone—Infestation—Etoposide—brain cancer	0.000182	0.00145	CcSEcCtD
Progesterone—NR3C1—spinal cord—brain cancer	0.000181	0.00434	CbGeAlD
Progesterone—Alopecia—Temozolomide—brain cancer	0.00018	0.00143	CcSEcCtD
Progesterone—Skin disorder—Hydroxyurea—brain cancer	0.00018	0.00143	CcSEcCtD
Progesterone—SIGMAR1—brain—brain cancer	0.000179	0.00429	CbGeAlD
Progesterone—Mental disorder—Temozolomide—brain cancer	0.000179	0.00142	CcSEcCtD
Progesterone—Neuropathy peripheral—Etoposide—brain cancer	0.000178	0.00142	CcSEcCtD
Progesterone—Back pain—Carmustine—brain cancer	0.000178	0.00141	CcSEcCtD
Progesterone—Erythema—Temozolomide—brain cancer	0.000177	0.00141	CcSEcCtD
Progesterone—Malnutrition—Temozolomide—brain cancer	0.000177	0.00141	CcSEcCtD
Progesterone—Jaundice—Etoposide—brain cancer	0.000177	0.00141	CcSEcCtD
Progesterone—Anorexia—Hydroxyurea—brain cancer	0.000177	0.00141	CcSEcCtD
Progesterone—Hypersensitivity—Procarbazine—brain cancer	0.000176	0.0014	CcSEcCtD
Progesterone—Testosterone—CYP2C9—brain cancer	0.000176	0.127	CrCbGaD
Progesterone—Vision blurred—Carmustine—brain cancer	0.000173	0.00138	CcSEcCtD
Progesterone—Tremor—Carmustine—brain cancer	0.000172	0.00137	CcSEcCtD
Progesterone—Asthenia—Procarbazine—brain cancer	0.000172	0.00137	CcSEcCtD
Progesterone—Hepatobiliary disease—Etoposide—brain cancer	0.000172	0.00137	CcSEcCtD
Progesterone—Back pain—Temozolomide—brain cancer	0.000172	0.00137	CcSEcCtD
Progesterone—CYP1A2—endocrine gland—brain cancer	0.000171	0.00409	CbGeAlD
Progesterone—CYP1B1—brain—brain cancer	0.00017	0.00408	CbGeAlD
Progesterone—Anaemia—Carmustine—brain cancer	0.00017	0.00135	CcSEcCtD
Progesterone—Pruritus—Procarbazine—brain cancer	0.000169	0.00135	CcSEcCtD
Progesterone—CYP1A1—endocrine gland—brain cancer	0.000168	0.00403	CbGeAlD
Progesterone—Vision blurred—Temozolomide—brain cancer	0.000167	0.00133	CcSEcCtD
Progesterone—Tremor—Temozolomide—brain cancer	0.000166	0.00132	CcSEcCtD
Progesterone—CYP1A1—head—brain cancer	0.000166	0.00398	CbGeAlD
Progesterone—Dyspnoea—Hydroxyurea—brain cancer	0.000165	0.00132	CcSEcCtD
Progesterone—Somnolence—Hydroxyurea—brain cancer	0.000165	0.00131	CcSEcCtD
Progesterone—Ill-defined disorder—Temozolomide—brain cancer	0.000165	0.00131	CcSEcCtD
Progesterone—CYP3A5—endocrine gland—brain cancer	0.000164	0.00394	CbGeAlD
Progesterone—Anaemia—Temozolomide—brain cancer	0.000164	0.00131	CcSEcCtD
Progesterone—Diarrhoea—Procarbazine—brain cancer	0.000164	0.0013	CcSEcCtD
Progesterone—NR3C1—endocrine gland—brain cancer	0.000163	0.00391	CbGeAlD
Progesterone—Dyspepsia—Hydroxyurea—brain cancer	0.000163	0.0013	CcSEcCtD
Progesterone—Angioedema—Temozolomide—brain cancer	0.000162	0.00129	CcSEcCtD
Progesterone—CYP2C9—endocrine gland—brain cancer	0.000162	0.00388	CbGeAlD
Progesterone—AR—brain—brain cancer	0.000161	0.00386	CbGeAlD
Progesterone—NR3C1—head—brain cancer	0.000161	0.00386	CbGeAlD
Progesterone—Decreased appetite—Hydroxyurea—brain cancer	0.000161	0.00128	CcSEcCtD
Progesterone—Urinary tract disorder—Etoposide—brain cancer	0.000161	0.00128	CcSEcCtD
Progesterone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00016	0.00127	CcSEcCtD
Progesterone—Malaise—Temozolomide—brain cancer	0.00016	0.00127	CcSEcCtD
Progesterone—Urethral disorder—Etoposide—brain cancer	0.00016	0.00127	CcSEcCtD
Progesterone—Fatigue—Hydroxyurea—brain cancer	0.00016	0.00127	CcSEcCtD
Progesterone—Vertigo—Temozolomide—brain cancer	0.000159	0.00127	CcSEcCtD
Progesterone—Convulsion—Carmustine—brain cancer	0.000159	0.00127	CcSEcCtD
Progesterone—Hypertension—Carmustine—brain cancer	0.000158	0.00126	CcSEcCtD
Progesterone—Constipation—Hydroxyurea—brain cancer	0.000158	0.00126	CcSEcCtD
Progesterone—Pain—Hydroxyurea—brain cancer	0.000158	0.00126	CcSEcCtD
Progesterone—Dizziness—Procarbazine—brain cancer	0.000158	0.00126	CcSEcCtD
Progesterone—ESR1—brain—brain cancer	0.000158	0.00379	CbGeAlD
Progesterone—Palpitations—Temozolomide—brain cancer	0.000157	0.00125	CcSEcCtD
Progesterone—Myalgia—Carmustine—brain cancer	0.000156	0.00124	CcSEcCtD
Progesterone—Chest pain—Carmustine—brain cancer	0.000156	0.00124	CcSEcCtD
Progesterone—Anxiety—Carmustine—brain cancer	0.000156	0.00124	CcSEcCtD
Progesterone—Cough—Temozolomide—brain cancer	0.000155	0.00123	CcSEcCtD
Progesterone—Erythema multiforme—Etoposide—brain cancer	0.000154	0.00123	CcSEcCtD
Progesterone—Convulsion—Temozolomide—brain cancer	0.000154	0.00122	CcSEcCtD
Progesterone—Hypertension—Temozolomide—brain cancer	0.000153	0.00122	CcSEcCtD
Progesterone—ABCC1—brain—brain cancer	0.000153	0.00367	CbGeAlD
Progesterone—Feeling abnormal—Hydroxyurea—brain cancer	0.000153	0.00122	CcSEcCtD
Progesterone—Eye disorder—Etoposide—brain cancer	0.000152	0.00121	CcSEcCtD
Progesterone—Vomiting—Procarbazine—brain cancer	0.000152	0.00121	CcSEcCtD
Progesterone—CYP1A1—central nervous system—brain cancer	0.000152	0.00363	CbGeAlD
Progesterone—Cardiac disorder—Etoposide—brain cancer	0.000151	0.00121	CcSEcCtD
Progesterone—Confusional state—Carmustine—brain cancer	0.000151	0.0012	CcSEcCtD
Progesterone—Myalgia—Temozolomide—brain cancer	0.000151	0.0012	CcSEcCtD
Progesterone—Arthralgia—Temozolomide—brain cancer	0.000151	0.0012	CcSEcCtD
Progesterone—Rash—Procarbazine—brain cancer	0.000151	0.0012	CcSEcCtD
Progesterone—Dermatitis—Procarbazine—brain cancer	0.000151	0.0012	CcSEcCtD
Progesterone—Anxiety—Temozolomide—brain cancer	0.00015	0.0012	CcSEcCtD
Progesterone—Headache—Procarbazine—brain cancer	0.00015	0.00119	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00015	0.00119	CcSEcCtD
Progesterone—Oedema—Carmustine—brain cancer	0.00015	0.00119	CcSEcCtD
Progesterone—Discomfort—Temozolomide—brain cancer	0.000149	0.00119	CcSEcCtD
Progesterone—Infection—Carmustine—brain cancer	0.000149	0.00119	CcSEcCtD
Progesterone—Angiopathy—Etoposide—brain cancer	0.000148	0.00118	CcSEcCtD
Progesterone—Dry mouth—Temozolomide—brain cancer	0.000148	0.00118	CcSEcCtD
Progesterone—Immune system disorder—Etoposide—brain cancer	0.000147	0.00117	CcSEcCtD
Progesterone—NR3C1—central nervous system—brain cancer	0.000147	0.00352	CbGeAlD
Progesterone—Mediastinal disorder—Etoposide—brain cancer	0.000147	0.00117	CcSEcCtD
Progesterone—Body temperature increased—Hydroxyurea—brain cancer	0.000146	0.00117	CcSEcCtD
Progesterone—Tachycardia—Carmustine—brain cancer	0.000146	0.00116	CcSEcCtD
Progesterone—Confusional state—Temozolomide—brain cancer	0.000146	0.00116	CcSEcCtD
Progesterone—Oedema—Temozolomide—brain cancer	0.000145	0.00115	CcSEcCtD
Progesterone—Anaphylactic shock—Temozolomide—brain cancer	0.000145	0.00115	CcSEcCtD
Progesterone—Alopecia—Etoposide—brain cancer	0.000144	0.00115	CcSEcCtD
Progesterone—Infection—Temozolomide—brain cancer	0.000144	0.00115	CcSEcCtD
Progesterone—NR3C1—cerebellum—brain cancer	0.000144	0.00344	CbGeAlD
Progesterone—Anorexia—Carmustine—brain cancer	0.000143	0.00114	CcSEcCtD
Progesterone—Nausea—Procarbazine—brain cancer	0.000142	0.00113	CcSEcCtD
Progesterone—Nervous system disorder—Temozolomide—brain cancer	0.000142	0.00113	CcSEcCtD
Progesterone—Skin disorder—Temozolomide—brain cancer	0.000141	0.00112	CcSEcCtD
Progesterone—Hypotension—Carmustine—brain cancer	0.00014	0.00111	CcSEcCtD
Progesterone—Hyperhidrosis—Temozolomide—brain cancer	0.00014	0.00111	CcSEcCtD
Progesterone—ABCB1—telencephalon—brain cancer	0.000139	0.00332	CbGeAlD
Progesterone—Anorexia—Temozolomide—brain cancer	0.000138	0.0011	CcSEcCtD
Progesterone—Back pain—Etoposide—brain cancer	0.000137	0.00109	CcSEcCtD
Progesterone—Hypersensitivity—Hydroxyurea—brain cancer	0.000137	0.00109	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000136	0.00109	CcSEcCtD
Progesterone—Muscle spasms—Etoposide—brain cancer	0.000136	0.00109	CcSEcCtD
Progesterone—Insomnia—Carmustine—brain cancer	0.000135	0.00108	CcSEcCtD
Progesterone—Paraesthesia—Carmustine—brain cancer	0.000135	0.00107	CcSEcCtD
Progesterone—Dyspnoea—Carmustine—brain cancer	0.000134	0.00106	CcSEcCtD
Progesterone—Somnolence—Carmustine—brain cancer	0.000133	0.00106	CcSEcCtD
Progesterone—Asthenia—Hydroxyurea—brain cancer	0.000133	0.00106	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000132	0.00105	CcSEcCtD
Progesterone—Ill-defined disorder—Etoposide—brain cancer	0.000132	0.00105	CcSEcCtD
Progesterone—Anaemia—Etoposide—brain cancer	0.000131	0.00104	CcSEcCtD
Progesterone—Insomnia—Temozolomide—brain cancer	0.000131	0.00104	CcSEcCtD
Progesterone—CYP2C8—brain—brain cancer	0.00013	0.00312	CbGeAlD
Progesterone—Decreased appetite—Carmustine—brain cancer	0.00013	0.00104	CcSEcCtD
Progesterone—Paraesthesia—Temozolomide—brain cancer	0.00013	0.00104	CcSEcCtD
Progesterone—Gastrointestinal disorder—Carmustine—brain cancer	0.000129	0.00103	CcSEcCtD
Progesterone—Dyspnoea—Temozolomide—brain cancer	0.000129	0.00103	CcSEcCtD
Progesterone—Somnolence—Temozolomide—brain cancer	0.000129	0.00102	CcSEcCtD
Progesterone—Constipation—Carmustine—brain cancer	0.000128	0.00102	CcSEcCtD
Progesterone—Pain—Carmustine—brain cancer	0.000128	0.00102	CcSEcCtD
Progesterone—Malaise—Etoposide—brain cancer	0.000128	0.00102	CcSEcCtD
Progesterone—Vertigo—Etoposide—brain cancer	0.000128	0.00102	CcSEcCtD
Progesterone—Dyspepsia—Temozolomide—brain cancer	0.000127	0.00101	CcSEcCtD
Progesterone—Diarrhoea—Hydroxyurea—brain cancer	0.000127	0.00101	CcSEcCtD
Progesterone—Decreased appetite—Temozolomide—brain cancer	0.000126	0.001	CcSEcCtD
Progesterone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000125	0.000995	CcSEcCtD
Progesterone—Fatigue—Temozolomide—brain cancer	0.000125	0.000994	CcSEcCtD
Progesterone—Loss of consciousness—Etoposide—brain cancer	0.000125	0.000993	CcSEcCtD
Progesterone—Cough—Etoposide—brain cancer	0.000124	0.000986	CcSEcCtD
Progesterone—Pain—Temozolomide—brain cancer	0.000124	0.000986	CcSEcCtD
Progesterone—Constipation—Temozolomide—brain cancer	0.000124	0.000986	CcSEcCtD
Progesterone—Feeling abnormal—Carmustine—brain cancer	0.000123	0.000983	CcSEcCtD
Progesterone—CYP3A4—endocrine gland—brain cancer	0.000123	0.00296	CbGeAlD
Progesterone—Convulsion—Etoposide—brain cancer	0.000123	0.000979	CcSEcCtD
Progesterone—Hypertension—Etoposide—brain cancer	0.000123	0.000976	CcSEcCtD
Progesterone—Dizziness—Hydroxyurea—brain cancer	0.000123	0.000976	CcSEcCtD
Progesterone—Gastrointestinal pain—Carmustine—brain cancer	0.000123	0.000976	CcSEcCtD
Progesterone—CYP2D6—endocrine gland—brain cancer	0.000121	0.00291	CbGeAlD
Progesterone—Chest pain—Etoposide—brain cancer	0.000121	0.000962	CcSEcCtD
Progesterone—CYP1A1—brain—brain cancer	0.00012	0.00288	CbGeAlD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00012	0.000956	CcSEcCtD
Progesterone—CYP2D6—head—brain cancer	0.00012	0.00287	CbGeAlD
Progesterone—Discomfort—Etoposide—brain cancer	0.000119	0.000951	CcSEcCtD
Progesterone—Feeling abnormal—Temozolomide—brain cancer	0.000119	0.00095	CcSEcCtD
Progesterone—Body temperature increased—Carmustine—brain cancer	0.000118	0.000943	CcSEcCtD
Progesterone—Abdominal pain—Carmustine—brain cancer	0.000118	0.000943	CcSEcCtD
Progesterone—Gastrointestinal pain—Temozolomide—brain cancer	0.000118	0.000943	CcSEcCtD
Progesterone—Vomiting—Hydroxyurea—brain cancer	0.000118	0.000938	CcSEcCtD
Progesterone—Rash—Hydroxyurea—brain cancer	0.000117	0.00093	CcSEcCtD
Progesterone—Confusional state—Etoposide—brain cancer	0.000117	0.00093	CcSEcCtD
Progesterone—NR3C1—brain—brain cancer	0.000117	0.0028	CbGeAlD
Progesterone—Dermatitis—Hydroxyurea—brain cancer	0.000117	0.00093	CcSEcCtD
Progesterone—Headache—Hydroxyurea—brain cancer	0.000116	0.000924	CcSEcCtD
Progesterone—Anaphylactic shock—Etoposide—brain cancer	0.000116	0.000923	CcSEcCtD
Progesterone—ABCB1—gonad—brain cancer	0.000116	0.00277	CbGeAlD
Progesterone—Infection—Etoposide—brain cancer	0.000115	0.000916	CcSEcCtD
Progesterone—Urticaria—Temozolomide—brain cancer	0.000115	0.000916	CcSEcCtD
Progesterone—Abdominal pain—Temozolomide—brain cancer	0.000114	0.000911	CcSEcCtD
Progesterone—Body temperature increased—Temozolomide—brain cancer	0.000114	0.000911	CcSEcCtD
Progesterone—Tachycardia—Etoposide—brain cancer	0.000113	0.0009	CcSEcCtD
Progesterone—ABCB1—pituitary gland—brain cancer	0.000113	0.0027	CbGeAlD
Progesterone—Skin disorder—Etoposide—brain cancer	0.000113	0.000896	CcSEcCtD
Progesterone—Hyperhidrosis—Etoposide—brain cancer	0.000112	0.000892	CcSEcCtD
Progesterone—CYP3A4—central nervous system—brain cancer	0.000111	0.00267	CbGeAlD
Progesterone—Anorexia—Etoposide—brain cancer	0.00011	0.000879	CcSEcCtD
Progesterone—Hypersensitivity—Carmustine—brain cancer	0.00011	0.000879	CcSEcCtD
Progesterone—Nausea—Hydroxyurea—brain cancer	0.00011	0.000877	CcSEcCtD
Progesterone—CYP2D6—central nervous system—brain cancer	0.000109	0.00262	CbGeAlD
Progesterone—ABCB1—medulla oblongata—brain cancer	0.000109	0.00261	CbGeAlD
Progesterone—Hypotension—Etoposide—brain cancer	0.000108	0.000862	CcSEcCtD
Progesterone—Asthenia—Carmustine—brain cancer	0.000107	0.000856	CcSEcCtD
Progesterone—CYP2D6—cerebellum—brain cancer	0.000107	0.00256	CbGeAlD
Progesterone—Hypersensitivity—Temozolomide—brain cancer	0.000107	0.000849	CcSEcCtD
Progesterone—Paraesthesia—Etoposide—brain cancer	0.000104	0.000828	CcSEcCtD
Progesterone—Asthenia—Temozolomide—brain cancer	0.000104	0.000827	CcSEcCtD
Progesterone—Dyspnoea—Etoposide—brain cancer	0.000103	0.000822	CcSEcCtD
Progesterone—Somnolence—Etoposide—brain cancer	0.000103	0.00082	CcSEcCtD
Progesterone—Diarrhoea—Carmustine—brain cancer	0.000102	0.000816	CcSEcCtD
Progesterone—Pruritus—Temozolomide—brain cancer	0.000102	0.000816	CcSEcCtD
Progesterone—Decreased appetite—Etoposide—brain cancer	0.000101	0.000802	CcSEcCtD
Progesterone—Gastrointestinal disorder—Etoposide—brain cancer	0.0001	0.000796	CcSEcCtD
Progesterone—Fatigue—Etoposide—brain cancer	9.99e-05	0.000795	CcSEcCtD
Progesterone—ABCB1—midbrain—brain cancer	9.95e-05	0.00238	CbGeAlD
Progesterone—Dizziness—Carmustine—brain cancer	9.91e-05	0.000789	CcSEcCtD
Progesterone—Pain—Etoposide—brain cancer	9.91e-05	0.000789	CcSEcCtD
Progesterone—Constipation—Etoposide—brain cancer	9.91e-05	0.000789	CcSEcCtD
Progesterone—Diarrhoea—Temozolomide—brain cancer	9.91e-05	0.000789	CcSEcCtD
Progesterone—ABCB1—spinal cord—brain cancer	9.71e-05	0.00233	CbGeAlD
Progesterone—Dizziness—Temozolomide—brain cancer	9.57e-05	0.000762	CcSEcCtD
Progesterone—Feeling abnormal—Etoposide—brain cancer	9.55e-05	0.00076	CcSEcCtD
Progesterone—Vomiting—Carmustine—brain cancer	9.52e-05	0.000759	CcSEcCtD
Progesterone—Gastrointestinal pain—Etoposide—brain cancer	9.47e-05	0.000754	CcSEcCtD
Progesterone—Rash—Carmustine—brain cancer	9.45e-05	0.000752	CcSEcCtD
Progesterone—Dermatitis—Carmustine—brain cancer	9.44e-05	0.000751	CcSEcCtD
Progesterone—Headache—Carmustine—brain cancer	9.38e-05	0.000747	CcSEcCtD
Progesterone—Vomiting—Temozolomide—brain cancer	9.2e-05	0.000733	CcSEcCtD
Progesterone—Urticaria—Etoposide—brain cancer	9.2e-05	0.000733	CcSEcCtD
Progesterone—Body temperature increased—Etoposide—brain cancer	9.16e-05	0.000729	CcSEcCtD
Progesterone—Abdominal pain—Etoposide—brain cancer	9.16e-05	0.000729	CcSEcCtD
Progesterone—Rash—Temozolomide—brain cancer	9.13e-05	0.000727	CcSEcCtD
Progesterone—Dermatitis—Temozolomide—brain cancer	9.12e-05	0.000726	CcSEcCtD
Progesterone—Headache—Temozolomide—brain cancer	9.07e-05	0.000722	CcSEcCtD
Progesterone—Nausea—Carmustine—brain cancer	8.9e-05	0.000709	CcSEcCtD
Progesterone—ABCB1—endocrine gland—brain cancer	8.74e-05	0.00209	CbGeAlD
Progesterone—CYP2D6—brain—brain cancer	8.69e-05	0.00208	CbGeAlD
Progesterone—ABCB1—head—brain cancer	8.63e-05	0.00207	CbGeAlD
Progesterone—Nausea—Temozolomide—brain cancer	8.6e-05	0.000685	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—brain cancer	8.53e-05	0.00068	CcSEcCtD
Progesterone—Asthenia—Etoposide—brain cancer	8.31e-05	0.000662	CcSEcCtD
Progesterone—Pruritus—Etoposide—brain cancer	8.2e-05	0.000653	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—brain cancer	7.93e-05	0.000631	CcSEcCtD
Progesterone—ABCB1—central nervous system—brain cancer	7.87e-05	0.00189	CbGeAlD
Progesterone—ABCB1—cerebellum—brain cancer	7.7e-05	0.00184	CbGeAlD
Progesterone—Dizziness—Etoposide—brain cancer	7.66e-05	0.00061	CcSEcCtD
Progesterone—Vomiting—Etoposide—brain cancer	7.37e-05	0.000587	CcSEcCtD
Progesterone—Rash—Etoposide—brain cancer	7.3e-05	0.000582	CcSEcCtD
Progesterone—Dermatitis—Etoposide—brain cancer	7.3e-05	0.000581	CcSEcCtD
Progesterone—Headache—Etoposide—brain cancer	7.26e-05	0.000578	CcSEcCtD
Progesterone—Nausea—Etoposide—brain cancer	6.88e-05	0.000548	CcSEcCtD
Progesterone—ABCB1—brain—brain cancer	6.25e-05	0.0015	CbGeAlD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.44e-05	0.000359	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.44e-05	0.000359	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	2.44e-05	0.000358	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.41e-05	0.000353	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.41e-05	0.000353	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HEY1—brain cancer	2.38e-05	0.00035	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.38e-05	0.00035	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ABR—brain cancer	2.37e-05	0.000348	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.36e-05	0.000347	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.35e-05	0.000345	CbGpPWpGaD
Progesterone—ABCC1—Disease—IDH1—brain cancer	2.34e-05	0.000344	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CYP2C9—brain cancer	2.34e-05	0.000344	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.34e-05	0.000343	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP2C9—brain cancer	2.34e-05	0.000343	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—DLL1—brain cancer	2.34e-05	0.000343	CbGpPWpGaD
Progesterone—PGR—Gene Expression—NOTCH2—brain cancer	2.32e-05	0.00034	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GLI2—brain cancer	2.29e-05	0.000336	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.29e-05	0.000336	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	2.29e-05	0.000335	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—BSG—brain cancer	2.28e-05	0.000335	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTCH2—brain cancer	2.27e-05	0.000332	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.24e-05	0.000328	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	2.24e-05	0.000328	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—EGFR—brain cancer	2.22e-05	0.000326	CbGpPWpGaD
Progesterone—ABCC1—Disease—HEY1—brain cancer	2.22e-05	0.000326	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—BSG—brain cancer	2.21e-05	0.000324	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.21e-05	0.000324	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HES5—brain cancer	2.19e-05	0.000322	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP2C9—brain cancer	2.18e-05	0.00032	CbGpPWpGaD
Progesterone—ABCC1—Disease—DLL1—brain cancer	2.18e-05	0.00032	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ENO2—brain cancer	2.15e-05	0.000316	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GLI1—brain cancer	2.15e-05	0.000316	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.15e-05	0.000315	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP2C9—brain cancer	2.15e-05	0.000315	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STRADA—brain cancer	2.13e-05	0.000313	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.13e-05	0.000312	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—VAV1—brain cancer	2.1e-05	0.000308	CbGpPWpGaD
Progesterone—AR—Gene Expression—DNMT1—brain cancer	2.08e-05	0.000305	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ENO2—brain cancer	2.07e-05	0.000303	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.06e-05	0.000302	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SUFU—brain cancer	2.04e-05	0.0003	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.02e-05	0.000296	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—BSG—brain cancer	1.99e-05	0.000292	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—BSG—brain cancer	1.99e-05	0.000292	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SHH—brain cancer	1.99e-05	0.000292	CbGpPWpGaD
Progesterone—PGR—Gene Expression—SIRT1—brain cancer	1.97e-05	0.000289	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GFAP—brain cancer	1.97e-05	0.000289	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—IDH1—brain cancer	1.96e-05	0.000288	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.96e-05	0.000288	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.93e-05	0.000284	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TRPC6—brain cancer	1.92e-05	0.000281	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—VAV1—brain cancer	1.9e-05	0.000279	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—IDH1—brain cancer	1.9e-05	0.000279	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.89e-05	0.000278	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SMO—brain cancer	1.88e-05	0.000277	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTCH1—brain cancer	1.88e-05	0.000277	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	1.88e-05	0.000275	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HEY1—brain cancer	1.87e-05	0.000274	CbGpPWpGaD
Progesterone—AR—Gene Expression—ESR2—brain cancer	1.86e-05	0.000274	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—BSG—brain cancer	1.85e-05	0.000272	CbGpPWpGaD
Progesterone—ABCC1—Disease—ENO2—brain cancer	1.85e-05	0.000272	CbGpPWpGaD
Progesterone—ABCC1—Disease—SHH—brain cancer	1.85e-05	0.000272	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.85e-05	0.000272	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—DLL1—brain cancer	1.83e-05	0.000269	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—BSG—brain cancer	1.83e-05	0.000268	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.82e-05	0.000267	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ABR—brain cancer	1.78e-05	0.000261	CbGpPWpGaD
Progesterone—AR—Gene Expression—NOTCH2—brain cancer	1.77e-05	0.000259	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GLI2—brain cancer	1.72e-05	0.000252	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—IDH1—brain cancer	1.71e-05	0.000251	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—IDH1—brain cancer	1.71e-05	0.000251	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP2C9—brain cancer	1.69e-05	0.000248	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.67e-05	0.000246	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GLI1—brain cancer	1.61e-05	0.000237	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PIK3CG—brain cancer	1.61e-05	0.000236	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—MYC—brain cancer	1.6e-05	0.000235	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—DNMT1—brain cancer	1.6e-05	0.000235	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000235	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.6e-05	0.000235	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—IDH1—brain cancer	1.59e-05	0.000234	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—DNMT1—brain cancer	1.58e-05	0.000231	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—IDH1—brain cancer	1.57e-05	0.00023	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SHH—brain cancer	1.56e-05	0.000228	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.56e-05	0.000228	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ENO2—brain cancer	1.55e-05	0.000228	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.55e-05	0.000227	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SUFU—brain cancer	1.53e-05	0.000225	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.52e-05	0.000223	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NOTCH2—brain cancer	1.51e-05	0.000221	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TRPC6—brain cancer	1.5e-05	0.00022	CbGpPWpGaD
Progesterone—AR—Gene Expression—SIRT1—brain cancer	1.5e-05	0.00022	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ENO2—brain cancer	1.5e-05	0.00022	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SMO—brain cancer	1.48e-05	0.000217	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTCH1—brain cancer	1.48e-05	0.000217	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GFAP—brain cancer	1.48e-05	0.000217	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000215	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—BSG—brain cancer	1.44e-05	0.000211	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VAV1—brain cancer	1.44e-05	0.000211	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—ESR2—brain cancer	1.44e-05	0.000211	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—ESR2—brain cancer	1.41e-05	0.000208	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.41e-05	0.000208	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HEY1—brain cancer	1.4e-05	0.000205	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—DLL1—brain cancer	1.37e-05	0.000201	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NOTCH2—brain cancer	1.36e-05	0.0002	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—BSG—brain cancer	1.36e-05	0.0002	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ENO2—brain cancer	1.35e-05	0.000199	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ENO2—brain cancer	1.35e-05	0.000198	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NOTCH2—brain cancer	1.34e-05	0.000197	CbGpPWpGaD
Progesterone—ABCC1—Disease—VAV1—brain cancer	1.34e-05	0.000196	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	1.33e-05	0.000195	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP2C9—brain cancer	1.31e-05	0.000192	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP2C9—brain cancer	1.28e-05	0.000187	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—MYC—brain cancer	1.27e-05	0.000186	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ENO2—brain cancer	1.26e-05	0.000185	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.25e-05	0.000183	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—BSG—brain cancer	1.25e-05	0.000183	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ENO2—brain cancer	1.24e-05	0.000182	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—IDH1—brain cancer	1.24e-05	0.000182	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.24e-05	0.000182	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HES1—brain cancer	1.24e-05	0.000181	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—MYC—brain cancer	1.22e-05	0.000179	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	1.21e-05	0.000177	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP2C9—brain cancer	1.2e-05	0.000177	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CG—brain cancer	1.18e-05	0.000173	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NOTCH2—brain cancer	1.18e-05	0.000173	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PDGFRA—brain cancer	1.18e-05	0.000173	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—IDH1—brain cancer	1.17e-05	0.000172	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SHH—brain cancer	1.17e-05	0.000171	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—SIRT1—brain cancer	1.16e-05	0.00017	CbGpPWpGaD
Progesterone—ABCC1—Disease—HES1—brain cancer	1.15e-05	0.000169	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SPP1—brain cancer	1.14e-05	0.000168	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—SIRT1—brain cancer	1.14e-05	0.000167	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TRPC6—brain cancer	1.13e-05	0.000165	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VAV1—brain cancer	1.12e-05	0.000165	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—BSG—brain cancer	1.11e-05	0.000163	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTCH1—brain cancer	1.11e-05	0.000162	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SMO—brain cancer	1.11e-05	0.000162	CbGpPWpGaD
Progesterone—ABCC1—Disease—PDGFRA—brain cancer	1.1e-05	0.000161	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.09e-05	0.00016	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—BSG—brain cancer	1.09e-05	0.000159	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—IDH1—brain cancer	1.07e-05	0.000157	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IRS2—brain cancer	1.03e-05	0.000152	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—BSG—brain cancer	1.02e-05	0.00015	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP2C9—brain cancer	1.02e-05	0.00015	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—BSG—brain cancer	1.01e-05	0.000149	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1e-05	0.000147	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CG—brain cancer	9.89e-06	0.000145	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	9.8e-06	0.000144	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ENO2—brain cancer	9.78e-06	0.000144	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HES1—brain cancer	9.68e-06	0.000142	CbGpPWpGaD
Progesterone—ABCC1—Disease—IRS2—brain cancer	9.63e-06	0.000141	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—IDH1—brain cancer	9.57e-06	0.00014	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.52e-06	0.00014	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CG—brain cancer	9.48e-06	0.000139	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—MYC—brain cancer	9.41e-06	0.000138	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—IL2—brain cancer	9.37e-06	0.000138	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—IDH1—brain cancer	9.34e-06	0.000137	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	9.27e-06	0.000136	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ENO2—brain cancer	9.24e-06	0.000136	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PDGFRA—brain cancer	9.21e-06	0.000135	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—APC—brain cancer	9.12e-06	0.000134	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CG—brain cancer	9.12e-06	0.000134	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SPP1—brain cancer	8.94e-06	0.000131	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOTCH2—brain cancer	8.84e-06	0.00013	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—IDH1—brain cancer	8.8e-06	0.000129	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.73e-06	0.000128	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—IDH1—brain cancer	8.73e-06	0.000128	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—BSG—brain cancer	8.67e-06	0.000127	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL2—brain cancer	8.51e-06	0.000125	CbGpPWpGaD
Progesterone—ABCC1—Disease—APC—brain cancer	8.5e-06	0.000125	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ENO2—brain cancer	8.47e-06	0.000124	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VAV1—brain cancer	8.43e-06	0.000124	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.23e-06	0.000121	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IRS2—brain cancer	8.09e-06	0.000119	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2C9—brain cancer	7.87e-06	0.000115	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.79e-06	0.000114	CbGpPWpGaD
Progesterone—PGR—Gene Expression—MYC—brain cancer	7.72e-06	0.000113	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ENO2—brain cancer	7.56e-06	0.000111	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—IDH1—brain cancer	7.46e-06	0.000109	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ENO2—brain cancer	7.38e-06	0.000108	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HES1—brain cancer	7.25e-06	0.000106	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CG—brain cancer	7.14e-06	0.000105	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—APC—brain cancer	7.14e-06	0.000105	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—RELA—brain cancer	7.13e-06	0.000105	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CG—brain cancer	7.12e-06	0.000104	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.1e-06	0.000104	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—ERBB2—brain cancer	7.08e-06	0.000104	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ENO2—brain cancer	6.96e-06	0.000102	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PDGFRA—brain cancer	6.9e-06	0.000101	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ENO2—brain cancer	6.9e-06	0.000101	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CG—brain cancer	6.89e-06	0.000101	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SPP1—brain cancer	6.7e-06	9.83e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—BSG—brain cancer	6.69e-06	9.82e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERBB2—brain cancer	6.6e-06	9.69e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—brain cancer	6.51e-06	9.55e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL2—brain cancer	6.42e-06	9.42e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCND1—brain cancer	6.26e-06	9.18e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CG—brain cancer	6.21e-06	9.11e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CG—brain cancer	6.2e-06	9.1e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CTNNB1—brain cancer	6.2e-06	9.09e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.07e-06	8.91e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IRS2—brain cancer	6.06e-06	8.89e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ENO2—brain cancer	5.89e-06	8.65e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—brain cancer	5.88e-06	8.63e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CG—brain cancer	5.78e-06	8.48e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—brain cancer	5.78e-06	8.47e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—IDH1—brain cancer	5.75e-06	8.44e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CG—brain cancer	5.69e-06	8.35e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RELA—brain cancer	5.58e-06	8.19e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB2—brain cancer	5.55e-06	8.14e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—brain cancer	5.45e-06	8e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—brain cancer	5.4e-06	7.93e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APC—brain cancer	5.35e-06	7.85e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CG—brain cancer	5.35e-06	7.85e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—brain cancer	5.03e-06	7.39e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—brain cancer	5.03e-06	7.38e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—brain cancer	5.02e-06	7.36e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—brain cancer	4.91e-06	7.2e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—brain cancer	4.9e-06	7.19e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—brain cancer	4.85e-06	7.12e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—brain cancer	4.68e-06	6.86e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—brain cancer	4.58e-06	6.71e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—brain cancer	4.55e-06	6.68e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—brain cancer	4.53e-06	6.65e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—brain cancer	4.49e-06	6.59e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—brain cancer	4.46e-06	6.55e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—brain cancer	4.27e-06	6.27e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—brain cancer	4.24e-06	6.22e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—brain cancer	4.23e-06	6.21e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RELA—brain cancer	4.18e-06	6.14e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—brain cancer	4.16e-06	6.1e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—brain cancer	4.12e-06	6.05e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—brain cancer	3.93e-06	5.77e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—brain cancer	3.89e-06	5.71e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—brain cancer	3.84e-06	5.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—brain cancer	3.77e-06	5.53e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—brain cancer	3.67e-06	5.39e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—brain cancer	3.64e-06	5.34e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—brain cancer	3.47e-06	5.09e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—brain cancer	3.39e-06	4.97e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—brain cancer	3.23e-06	4.74e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—brain cancer	3.2e-06	4.7e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—brain cancer	3.19e-06	4.68e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—brain cancer	3.17e-06	4.65e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—brain cancer	3.16e-06	4.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—brain cancer	2.95e-06	4.32e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—brain cancer	2.88e-06	4.23e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—brain cancer	2.7e-06	3.97e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—brain cancer	2.42e-06	3.55e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—brain cancer	2.09e-06	3.06e-05	CbGpPWpGaD
